Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06429436 · ClinicalTrials.gov registry record · Phase 4
Vending Machine Naloxone Distribution for Your Community (VENDY)
A Phase 4 study of Opioid Overdose and Harm Reduction, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 4,000
- Enrollment target
- 3
- Study locations
NCT06429436 is a Phase 4 study of Opioid Overdose and Harm Reduction that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 4,000 participants, roughly in line with the 3,742-participant average among 8 other Opioid Overdose trials with a reported enrollment target. The trial reports 3 study locations across 1 state.
The verdict
NCT06429436, a Phase 4 study of Opioid Overdose and Harm Reduction, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 4,000 participants
- Enrollment target
- 3
- Study locations
Study Summary
Vending machines are an innovative strategy shown to increase access to naloxone, a medication used to reverse opioid overdose. The aim of this proposal is to study the reach of a community-initiated, stakeholder engaged adaptation of naloxone distribution, VEnding machine Naloxone Distribution for Your community (VENDY) program.
Conditions Studied
Interventions
- BEHAVIORAL VENDY
Study Locations (3)
Colorado
- Denver Health - Denver
- Summit County Public Health Department - Frisco
- Southern Colorado Harm Reduction Association - Pueblo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2024-06-01 |
| Est. Completion | 2026-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06429436
The ClinicalTrials.gov registry entry for NCT06429436 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 3,742-participant average among 8 other Opioid Overdose trials with a reported enrollment target. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Opioid Overdose appearing as the primary indexed condition, and to 1 intervention - of which VENDY is the first listed.
NCT06429436 reports 3 study locations spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT06429436 about?
NCT06429436 is a clinical study titled "Vending Machine Naloxone Distribution for Your Community (VENDY)". Vending machines are an innovative strategy shown to increase access to naloxone, a medication used to reverse opioid overdose. The aim of this proposal is to study the reach of a community-initiated, stakeholder engaged adaptation of naloxone distribution, VEnding machine Naloxone Distribution for ...
What is the current status of trial NCT06429436?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 4,000 participants. The study started on 2024-06-01. Estimated completion is 2026-06-30.
What conditions does trial NCT06429436 study?
This clinical trial studies the following conditions: Opioid Overdose, Harm Reduction, Naloxone.
What interventions are being tested in trial NCT06429436?
The interventions under investigation include: VENDY (BEHAVIORAL).
Who is sponsoring clinical trial NCT06429436?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06429436 being conducted?
This trial has 3 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Overdose
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Young Houston Emergency Opioid Engagement System
RECRUITING · Phase 4
-
Improving Availability of Intranasal Naloxone
RECRUITING · NA
-
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
RECRUITING · NA
-
A Bundled Intervention
RECRUITING · Phase 1
-
Quantitative Xylazine Measurement in ED
RECRUITING
-
Health Insurance Instability and Mortality Among Patients Receiving Bup Tx for OUD
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.